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Purpose/Objective: Cherenkov emission from water tank is 
possible at 20 frames per second acquisition, and so this 
allows direct high resolution visualization of the delivery of 
IMRT and VMAT plans for the first time ever. This study 
focuses on the temporal and spatial capabilities of the first 
2+D, and 3D Cherenkov water imaging systems.  
Materials and Methods: Cherenkov emission was imaged from 
a standard water tank, with 1g/L quinine sulphate in 
solution. The emission was detected using a time-gated ICCD 
camera synchronized to the LINAC pulses at 200Hz. Images 
were collected at 20Hz with room lights on, using background 
acquisition and subtraction. 2+D imaging of TG-119 plans was 
done with imaging treatments from one perspective. 3D 
imaging was done for a static beam by rotating the water 
tank and camera through 360 degrees during imaging.  
Results: 2+D imaging of delivery can be achieved with 
extremely high resolution (300 microns) using the appropriate 
lens and ICCD, and the ability to capture the volumetric 
temporal kinetics of delivery is unique to this type of imaging 
system. The agreement between Cerenkov image and dose 
map from the treatment planning system was greater than 
96% from gamma analysis using a 3%/3mm criteria. 3D 
imaging of individual beams illustrates how high resolution 
features of the MLC can be captured, and even leakage 
radiation through the closed MLCs and the end leakage can 
be visualized with high SNR.  
Conclusions: The niche area of Cherenkov imaging of 
IRMT/VMAT delivery in water tanks can allow for high 
resolution fast data acquisition. The agreement between 
Cherenkov emission and dose is very good, indicating it 
should be acceptable as a surrogate measure of dose under 
certain conditions.  
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Purpose/Objective: Tumour delineation is a challenging and 
time-consuming part of radiotherapy planning. The task has 
become more complex with the increased popularity of 
multi-sequence and multimodal imaging. The purpose of this 
study was to investigate how we could combine images from 
different MR sequences and use them for automatic 
segmentation of cervical cancer tumours. 
Materials and Methods: Seventy-eight patients with 
advanced cervical cancer where imaged using three different 
MRI sequences: T2-weighted MRI, T1-weighted MRI and 
dynamic contrast enhanced (DCE) MRI. These images were 
used separately or in combination as input to a Fisher’s 
Linear Discriminant Analysis classifier. We trained the 
classifier to identify each voxel as either tumour or non-
tumour, using the radiologist’s delineations as ground truth. 
The segmentation results provided probability maps, giving 
the probability of each voxel belonging to the tumour. We 
used leave-one-patient-out cross-validation to assess the 
classifier’s performance.  
Results: The best segmentation model resulted in a Dice 
similarity coefficient of 0.37 and a Kappa value of 0.33 after 
cross-validation. This result is similar to the results from a 
previous study of agreement between radiologists. The DCE-
MRI time series significantly improved tumour segmentation. 
The T1-weighted images gave a smaller, but also significant, 
increase in performance. Even though the radiologist used 
the T2-weighted images for delineation, these images did not 
improve the performance of the automatic segmentation 
model.  
Conclusions: Our results suggest that DCE-MRI and T1-
weighted MRI contain information relevant for automatic 
cervical tumour segmentation. The proposed method can 
easily be extended to include other image types, for example 
diffusion weighted MRI. 
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Purpose/Objective: Palliative radiation therapy (RT) is a 
common modality in the management of bone metastases 
(BoneMet) from prostate cancer (PCa). Pain control can be 
achieved with conventional EBRT and may be further 
improved with SBRT. In this study, we propose, for the first 
time, to utilize 18F-NaF PET/CT to identify regions within the 
conventional BoneMet target volumes that may have 
different biology and thus allowing RT dose escalation to 
potentially attain tumor control.  
Materials and Methods: As a proof-of-concept, eight patients 
with BoneMet from PCa who had 18F-NaF PET/CT scan prior to 
treatment were retrospectively included in this study. Two 
gross tumor volumes (GTV) were generated for each patient: 
GTVreg was delineated according to the regular tumor 
boundary shown in PET and/or CT images; GTVSUV60% was 
contoured based on 60% of the maximum standardized uptake 
values with adjustment by a clinician. The planning target 
volumes (PTVs) (PTVreg and PTVSUV60%) were defined as 
respective GTVs with a 3-mm isotropic expansion margin. The 
surrounding normal structures were contoured according to 
Radiation Therapy Oncology Group (RTOG) protocol 0631. 
Two 1-fraction SBRT plans using Volumetric Modulated Arc 
Therapy (VMAT) technique were created: (Plan24Gy and Plan24-
30Gy; 10 MV flattened filter free (FFF) beams, two full arcs and 
one partial arc if needed, 1400MU/min in a Varian TrueBeam 
Linear Accelerator) were generated for each patient. The 
regular Plan24Gy included a dose of 24 Gy prescribed to PTVreg. 
The dose escalation plan (Plan24-30Gy) consisted of a dose of 24 
Gy prescribed to PTVreg and a boost dose of 30Gy prescribed 
to the PTVSUV60%. The feasibility of using 18F-NaF PET-guided 
SBRT dose boost to 30 Gy was evaluated by its ability to 
reach that at least 90% of the PTV volume received 100% of 
the prescription dose while adhering to dose constraints. 
Tumor control probabilities (TCP) based on PET scan-defined 
volumes and the normal tissue complication probabilities 
(NTCP) were also compared between the plans.  
Results: In all 16 SBRT plans generated, the target volume 
objectives and the organs-at-risk (OARs) dose constraints 
were met without exception. The use of pre-treatment 18F-
NaF PET/CT led to a better estimate of the dominant lesion 
areas within routine GTV, which translated into an 
advantageous escalation of target dose. Plan24-30Gy had a 
significantly higher dose in PTVSUV60% than Plan79Gy (p < 0.001), 




Conclusions: Using VMAT with FFF beams to incorporate a 
simultaneous 18F-NaF PET-guided radiation boost dose of 30 
Gy into a SBRT plan is technically feasible without violating 
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theoretical normal tissue tolerances.The relationship 
between local control and normal tissue toxicity during 18F-
NaF PET-guided dose escalation in SBRT should be validated 
in clinical trials. 
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Purpose/Objective: Accuracy in lesion volume definition in 
radiotherapy ( RT) treatment is significant important in order 
to achieve local control and limiting toxicity to surrounding 
normal tissues. Integrating molecular imaging information as 
obtained from PET into RT treatment planning has been 
proved to significantly improve target volume delineation for 
various pathological entities. Several PET tumor 
segmentation algorithms have been proposed. However, not 
consensus seems to emerge and most of them suffer from 
validation weakness due to the small size and low quality of 
the validation sets. In this work a semi-automated 
thresholding-based algorithm for tumor segmentation in 
retrospectively gated ( RG) PET images is evaluated with a 
wide set of images. 
Materials and Methods: The algorithm is based on contrast 
oriented algorithm and adapted to RG-PET images. The semi-
automated character of this algorithm relies on that the user 
is required to indicate a tumor pixel in an image from one of 
the frames and subsequently, the target volume is 
automatically delineated in all frames. For this algorithm 
evaluation, the set of images employed involves 
experimental phantom measurements and clinical data. With 
experimental phantom measurements, algorithm accuracy 
and its robustness for different target movements are 
validated. In clinical data, discrepancy evaluation based on 
mis-segmented pixels between algorithm outcome and 
consensus ( Simultaneous Truth and Performance Level 
Estimation-STAPLE) of three manual contours by experts is 
reported for 8 lung cancer patients. The influence of 
heterogeneity and volume of the target on the discrepancy 
reported is also involved. 
Results: From the results reported in the evaluation with 
experimental phantom measurements, good accuracy and 
robustness for a broad range of cases can be concluded: no 
statistically significant diameter differences for different 
target movements and volumes; repeatability for 
heterogeneous and irregular targets independently of user 
initial interaction and accuracy in target tracking position for 
experimental phantoms and clinical data. In addition, in 
clinical evaluation, lesion position and extension provided by 
the algorithm is in reasonable agreement with the STAPLE 
consensus of 3 manual contours by experts. 
Conclusions: The evaluation with phantom experimental 
measurements presented in this work permits to 
independently evaluate the effects in algorithm response for 
different parameters. Moreover, with clinical data, 
comparison between tumor contoured by experts and by the 
algorithm permits to evaluate if the algorithm advantages, 
related to saving effort and time from the clinician tasks, are 
not in expenses of a poorer information extracted from the 
image. From the results reported in this evaluation, it is 
reasonable to consider the feasibility of this tool in order to 
study the improvements that RG- PET tumor segmentation 
can introduce in RT planning. 
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Purpose/Objective: To evaluate the CT number accuracy of 
a new Metal Artifact Reduction (MAR, GE Healthcare) 
algorithm for hip prostheses in radiation therapy. 
Materials and Methods: The CIRS Electron Density phantom 
was scanned at 120 kVp on a GE Optima CT580 CT simulator. 
Five cases were taken into consideration. The first and 
baseline case (A) simulated a patient without metallic hip 
implant. The next three cases simulated a patient with a 
unilateral hip implant (B: titanium (4.5g/cm3), C: stainless 
steel prosthesis (8g/cm3), D: lead (11.4g/cm3)) and the last 
case (E) simulated a patient with a bilateral lead hip implant. 
Lead rods were employed to challenge MAR algorithm due to 
his very high density. All the cases were reconstructed with 
and without MAR algorithm. 
Results: CT numbers (ΔCTn) and image noise (ΔσnCT) range 
differences between the baseline (case A) and the others 
cases are presented below. 
 
Table 1: Summary of the comparison results 
Non-MAR MAR 
Case B : Unilateral hip implant simulation with titanium 
insert 
ΔCTn (HU) ΔσCTn (HU) ΔCTn (HU) ΔσCTn (HU) 
[-3.9;3.4] [-7.0;1.7] [-3.7;1.0] [-8.4;4.4] 
Case C : Unilateral hip implant simulation with stainless 
steel prosthesis 
ΔCTn (HU) ΔσCTn (HU) ΔCTn (HU) ΔσCTn (HU) 
[-63.3;63.2] [-0.8;22.9] [-11.9;6.8] [-1.2;9.0] 
Case D : Unilateral hip implant simulation with lead rod 
ΔCTn (HU) ΔσCTn (HU) ΔCTn (HU) ΔσCTn (HU) 
[-81.2;75.9] [-0.8;20.0] [-18.0;4.5] [-0.8;9.4] 
Case E : Bilateral hip implant simulation with lead rods 
ΔCTn (HU) ΔσCTn (HU) ΔCTn (HU) ΔσCTn (HU) 
[-383.4;95.2] [6.7;281.2] [-60.1;40.8] [-0.3;34.8] 
 
Conclusions: This study seems to indicate that the MAR 
algorithm can reduce metal artifacts, improve the CT number 
accuracy and decrease the noise in corrected images for 
patients with hip prostheses. For the unilateral hip implant 
simulation, results are similar with or without MAR 
reconstruction for the titanium insert. Indeed, not enough 
artifacts were created due to the thickness of the titanium 
insert used (6mm diameter). Better results were obtained 
